Intravenous Delivery of Adeno-Associated Viral Vector Serotype 9 Mediates Effective Gene Expression in Ischemic Stroke Lesion and Brain Angiogenic Foci
Author(s) -
Fanxia Shen,
Robert Kuo,
Marine Milon-Camus,
Zhenying Han,
Lidan Jiang,
William L. Young,
Hua Su
Publication year - 2012
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.112.662965
Subject(s) - medicine , angiogenesis , adeno associated virus , genetic enhancement , gene delivery , pathology , lesion , viral vector , stroke (engine) , gene expression , immunology , vector (molecular biology) , cancer research , gene , biology , recombinant dna , mechanical engineering , biochemistry , engineering
Adeno-associated viral vector (AAV) is a powerful tool for delivering genes to treat brain diseases. Intravenous delivery of a self-complementary but not single-stranded AAV9 (ssAAV9) mediates robust gene expression in the adult brain. We tested if ssAAV9 effectively mediates gene expression in the ischemic stroke lesion and angiogenic foci.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom